findmyKOL

Fernando Martinez, MD

Enriched profile

Professor of Medicine; Academic Chief, Division of Pulmonary, Allergy, and Critical Care Medicine; Vice Chair for Clinical and Translational Research, Department of Medicine; Joseph D. Early Chair in Biomedical Research · University of Massachusetts Chan Medical School

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Worcester, MA · Northeast · United StatesSpecialtyPulmonary DiseaseFocusIdiopathic Pulmonary Fibrosis+2
Active KOLfindmyKOL type: NationalLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2024–2025

Fernando Martinez is Professor of Medicine; Academic Chief, Division of Pulmonary, Allergy, and Critical Care Medicine; Vice Chair for Clinical and Translational Research, Department of Medicine; Joseph D. Early Chair in Biomedical Research at University of Massachusetts Chan Medical School. OpenAlex indexes 1,314 publications with 141,679 citations (h-index 157); ClinicalTrials.gov lists 34 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Pulmonary Disease profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 13 Oct 2026

Fernando Martinez, MD, is Professor of Medicine at University of Massachusetts Chan Medical School. The public record shows 1,314 publications with 141,679 citations (h-index 157), centered on Idiopathic Pulmonary Fibrosis, COPD, Asthma. It also documents an investigator role on 34 registered clinical trials, industry payments reported by 16 companies, 3 NIH-funded awards (2024–2025).

  • Most recent indexed publication: 2026 · Research square
  • Top research focus: Idiopathic Pulmonary Fibrosis
  • 34 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 16 companies

Generated from the cited public record · current as of 13 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Lung Diseases14 trialsAsthma11 trialsIdiopathic Pulmonary Fibrosis10 trialsCOPD8 trialsRespiratory Sounds3 trialsRheumatoid Arthritis1 trialOsteoarthritis1 trialPain1 trialWounds and Injuries1 trialHypertension1 trialLung Diseases, Interstitial1 trial

Research focus

OpenAlex concept fingerprint
Idiopathic Pulmonary FibrosisCOPDAsthma

Drugs & molecules

across trials, industry payments and publications
Ofevgeneric · NintedanibClinical trials—Industry payments38Publications—Breztrigeneric · Budesonide / formoterol / glycopyrroniumClinical trials—Industry payments13Publications—Dupixentgeneric · DupilumabClinical trials—Industry payments8Publications—AlbuterolClinical trials—Industry payments3Publications—FluticasoneClinical trials—Industry payments3Publications—Fluticasone propionate; salmeterol xinafoateClinical trials—Industry payments3Publications—

Works with

trial sponsors and companies reporting payments
Boehringer Ingelheim International GmbHClinical trials—Industry payments54AstraZeneca UK LimitedClinical trials—Industry payments47AstraZeneca Pharmaceuticals LPClinical trials—Industry payments24GlaxoSmithKline, LLC.Clinical trials—Industry payments10Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments8Chiesi USA, Inc.Clinical trials—Industry payments7Zambon USA Ltd.Clinical trials—Industry payments7National Heart, Lung, and Blood Institute (NHLBI)Clinical trials5Industry payments—AstraZeneca ABClinical trials—Industry payments4Milton S. Hershey Medical CenterClinical trials4Industry payments—Weill Medical College of Cornell UniversityClinical trials4Industry payments—Duke UniversityClinical trials3Industry payments—E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments3Teva Pharmaceuticals USA, Inc.Clinical trials—Industry payments3University of Massachusetts, WorcesterClinical trials3Industry payments—University of MichiganClinical trials3Industry payments—University of MinnesotaClinical trials3Industry payments—Genzyme CorporationClinical trials—Industry payments2Hal ChapmanClinical trials2Industry payments—University of ArizonaClinical trials2Industry payments—Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments1Chiesi Farmaceutici S.p.A.Clinical trials1Industry payments—CSL BehringClinical trials—Industry payments1Fernando J MartinezClinical trials1Industry payments—Johns Hopkins UniversityClinical trials1Industry payments—Limacorporate S.p.aClinical trials1Industry payments—Novartis Pharmaceuticals CorporationClinical trials—Industry payments1Roche Products LimitedClinical trials—Industry payments1Sanofi Us Services Inc.Clinical trials—Industry payments1Zimmer, GmbHClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
1,314publications

Distinct works indexed by OpenAlex, matched via ORCID; 50 in PubMed.

141,679citations

Total citations across indexed works.

157h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
34clinical trials

Investigator role on registered studies.

View trials ↓
16companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
3NIH grants · 2024–2025

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 13 Oct 2026

Listed as an investigator on 34 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 13 Oct 2026

16 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    100%
    Corticosteroid100%
    Prednisone100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 13 Oct 2026

3 NIH research awards on record, funded 2024–2025 per NIH RePORTER. The latest:

Publications

Updated 13 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 13 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/fernando-martinez-md-5f024dc3

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • Doximity

    doximity.com/pub/fernando-martinez-md-65eebef8

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • Doximity

    doximity.com/pub/fernando-martinez-md-8cc65141

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • LinkedIn

    linkedin.com/in/fernando-martinez-02765350

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • Other

    profiles.umassmed.edu/display/47476089

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.umassmed.edu ↗
  • Google Scholar

    scholar.google.com/citations

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholar.google.com ↗
  • ResearchGate

    researchgate.net/scientific-contributions/Fernando-J-Martinez-2168902498

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗

Mentions by others

where others cite or feature them
  • Facebook

    facebook.com/umasschan/photos/fernando-martinez-md-is-leading-the-clinical-trial-for-a-study-involving-the-us-/1443342734458382

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗
  • Other

    ajmc.com/view/interview-with-fernando-j-martinez-md-ms-evolving-standards-and-emerging-treatments-in-copd-care

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ajmc.com ↗
  • X / Twitter

    x.com/UMassChan/status/1978836204066935119

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗
  • X / Twitter

    x.com/UMass_Medicine/status/1806017569792372911

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗
  • X / Twitter

    x.com/UMass_Medicine/status/1978877356795179031

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗
  • LinkedIn

    LinkedIn profile listed under "Fernando Martinez - Weill Cornell Medicine" (legacy/unclaimed employer label, not yet updated to UMass Chan)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 13 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    University of Florida College of Medicine, Gainesville, FL

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.umassmed.edu ↗
  • BS

    Interdisciplinary Sciences, University of Florida, Gainesville, FL

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.umassmed.edu ↗
  • MS

    Biostatistics & Clinical Study, University of Michigan, Ann Arbor, MI

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.umassmed.edu ↗
  • Board certified

    Internal Medicine (American Board of Internal Medicine)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →connect.medicalnewstoday.com ↗
  • Board certified

    Pulmonary Disease (American Board of Internal Medicine)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →connect.medicalnewstoday.com ↗

Editorial & leadership roles

journal and society appointments
  • Editor-in-Chief

    American Journal of Respiratory and Critical Care Medicine (AJRCCM, the "Blue Journal")

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →atsjournals.org ↗
  • Member

    Program Committee, ATS Assembly on Clinical Problems (American Thoracic Society)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →thoracic.org ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.